SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS

FIELD: chemistry.SUBSTANCE: invention relates to organic chemistry and notably to specific imidazo[4,5-c]pyridine derivatives. Invention also relates to a pharmaceutical composition based on a specific imidazo[4,5-c]pyridine derivative useful in treating cancer.EFFECT: technical result is obtaining...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SAMALA Dzhajya Prakash, KAMMARANO Karolin Mishel, ROJTERSHAN Majkl Khejl, DOLL Ronald Dzh, PANDA Dzhagannatkh, YAN Lipin, BODZHEN Stefan L, TROTTER B. Uesli, GKHOSH Partkha, BOLISETTI Ragkhu, VOSS Mettyu E, FRADERA LINAS Fransesk Ksaver, ALTMAN Majkl D, TOMPSON Kristofer Frensis, MARTINES Mishel, MASHASEK Mishell, KRISTOFER Mettyu P, SUN Binyuan, SIDZUKA Manami, TONI KURISSERI Antkhappan
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SAMALA Dzhajya Prakash
KAMMARANO Karolin Mishel
ROJTERSHAN Majkl Khejl
DOLL Ronald Dzh
PANDA Dzhagannatkh
YAN Lipin
BODZHEN Stefan L
TROTTER B. Uesli
GKHOSH Partkha
BOLISETTI Ragkhu
VOSS Mettyu E
FRADERA LINAS Fransesk Ksaver
ALTMAN Majkl D
TOMPSON Kristofer Frensis
MARTINES Mishel
MASHASEK Mishell
KRISTOFER Mettyu P
SUN Binyuan
SIDZUKA Manami
TONI KURISSERI Antkhappan
description FIELD: chemistry.SUBSTANCE: invention relates to organic chemistry and notably to specific imidazo[4,5-c]pyridine derivatives. Invention also relates to a pharmaceutical composition based on a specific imidazo[4,5-c]pyridine derivative useful in treating cancer.EFFECT: technical result is obtaining novel imidazopyridine derivatives useful as HDM2 protein inhibitors.17 cl, 1 dwg, 21 tbl, 360 ex Изобретение относится к области органической химии, а именно к конкретным производным имидазо[4,5-c]пиридина. Также изобретение относится к фармацевтической композиции на основе конкретного производного имидазо[4,5-c]пиридина, полезной для лечения рака. Технический результат: получены новые производные имидазопиридина, полезные в качестве ингибиторов HDM2 белка. 6 н. и 11 з.п. ф-лы, 1 ил., 21 табл., 360 пр.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2690663C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2690663C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2690663C23</originalsourceid><addsrcrecordid>eNrjZNAPDnUKDvEMCQ1xdVHw9PV0cYzyD4gM8nTx9HMNVnAMVvBw8TVS8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfFBoUZmlgZmZsbORsZEKAEA74MmJg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS</title><source>esp@cenet</source><creator>SAMALA Dzhajya Prakash ; KAMMARANO Karolin Mishel ; ROJTERSHAN Majkl Khejl ; DOLL Ronald Dzh ; PANDA Dzhagannatkh ; YAN Lipin ; BODZHEN Stefan L ; TROTTER B. Uesli ; GKHOSH Partkha ; BOLISETTI Ragkhu ; VOSS Mettyu E ; FRADERA LINAS Fransesk Ksaver ; ALTMAN Majkl D ; TOMPSON Kristofer Frensis ; MARTINES Mishel ; MASHASEK Mishell ; KRISTOFER Mettyu P ; SUN Binyuan ; SIDZUKA Manami ; TONI KURISSERI Antkhappan</creator><creatorcontrib>SAMALA Dzhajya Prakash ; KAMMARANO Karolin Mishel ; ROJTERSHAN Majkl Khejl ; DOLL Ronald Dzh ; PANDA Dzhagannatkh ; YAN Lipin ; BODZHEN Stefan L ; TROTTER B. Uesli ; GKHOSH Partkha ; BOLISETTI Ragkhu ; VOSS Mettyu E ; FRADERA LINAS Fransesk Ksaver ; ALTMAN Majkl D ; TOMPSON Kristofer Frensis ; MARTINES Mishel ; MASHASEK Mishell ; KRISTOFER Mettyu P ; SUN Binyuan ; SIDZUKA Manami ; TONI KURISSERI Antkhappan</creatorcontrib><description>FIELD: chemistry.SUBSTANCE: invention relates to organic chemistry and notably to specific imidazo[4,5-c]pyridine derivatives. Invention also relates to a pharmaceutical composition based on a specific imidazo[4,5-c]pyridine derivative useful in treating cancer.EFFECT: technical result is obtaining novel imidazopyridine derivatives useful as HDM2 protein inhibitors.17 cl, 1 dwg, 21 tbl, 360 ex Изобретение относится к области органической химии, а именно к конкретным производным имидазо[4,5-c]пиридина. Также изобретение относится к фармацевтической композиции на основе конкретного производного имидазо[4,5-c]пиридина, полезной для лечения рака. Технический результат: получены новые производные имидазопиридина, полезные в качестве ингибиторов HDM2 белка. 6 н. и 11 з.п. ф-лы, 1 ил., 21 табл., 360 пр.</description><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190605&amp;DB=EPODOC&amp;CC=RU&amp;NR=2690663C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190605&amp;DB=EPODOC&amp;CC=RU&amp;NR=2690663C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAMALA Dzhajya Prakash</creatorcontrib><creatorcontrib>KAMMARANO Karolin Mishel</creatorcontrib><creatorcontrib>ROJTERSHAN Majkl Khejl</creatorcontrib><creatorcontrib>DOLL Ronald Dzh</creatorcontrib><creatorcontrib>PANDA Dzhagannatkh</creatorcontrib><creatorcontrib>YAN Lipin</creatorcontrib><creatorcontrib>BODZHEN Stefan L</creatorcontrib><creatorcontrib>TROTTER B. Uesli</creatorcontrib><creatorcontrib>GKHOSH Partkha</creatorcontrib><creatorcontrib>BOLISETTI Ragkhu</creatorcontrib><creatorcontrib>VOSS Mettyu E</creatorcontrib><creatorcontrib>FRADERA LINAS Fransesk Ksaver</creatorcontrib><creatorcontrib>ALTMAN Majkl D</creatorcontrib><creatorcontrib>TOMPSON Kristofer Frensis</creatorcontrib><creatorcontrib>MARTINES Mishel</creatorcontrib><creatorcontrib>MASHASEK Mishell</creatorcontrib><creatorcontrib>KRISTOFER Mettyu P</creatorcontrib><creatorcontrib>SUN Binyuan</creatorcontrib><creatorcontrib>SIDZUKA Manami</creatorcontrib><creatorcontrib>TONI KURISSERI Antkhappan</creatorcontrib><title>SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS</title><description>FIELD: chemistry.SUBSTANCE: invention relates to organic chemistry and notably to specific imidazo[4,5-c]pyridine derivatives. Invention also relates to a pharmaceutical composition based on a specific imidazo[4,5-c]pyridine derivative useful in treating cancer.EFFECT: technical result is obtaining novel imidazopyridine derivatives useful as HDM2 protein inhibitors.17 cl, 1 dwg, 21 tbl, 360 ex Изобретение относится к области органической химии, а именно к конкретным производным имидазо[4,5-c]пиридина. Также изобретение относится к фармацевтической композиции на основе конкретного производного имидазо[4,5-c]пиридина, полезной для лечения рака. Технический результат: получены новые производные имидазопиридина, полезные в качестве ингибиторов HDM2 белка. 6 н. и 11 з.п. ф-лы, 1 ил., 21 табл., 360 пр.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPDnUKDvEMCQ1xdVHw9PV0cYzyD4gM8nTx9HMNVnAMVvBw8TVS8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfFBoUZmlgZmZsbORsZEKAEA74MmJg</recordid><startdate>20190605</startdate><enddate>20190605</enddate><creator>SAMALA Dzhajya Prakash</creator><creator>KAMMARANO Karolin Mishel</creator><creator>ROJTERSHAN Majkl Khejl</creator><creator>DOLL Ronald Dzh</creator><creator>PANDA Dzhagannatkh</creator><creator>YAN Lipin</creator><creator>BODZHEN Stefan L</creator><creator>TROTTER B. Uesli</creator><creator>GKHOSH Partkha</creator><creator>BOLISETTI Ragkhu</creator><creator>VOSS Mettyu E</creator><creator>FRADERA LINAS Fransesk Ksaver</creator><creator>ALTMAN Majkl D</creator><creator>TOMPSON Kristofer Frensis</creator><creator>MARTINES Mishel</creator><creator>MASHASEK Mishell</creator><creator>KRISTOFER Mettyu P</creator><creator>SUN Binyuan</creator><creator>SIDZUKA Manami</creator><creator>TONI KURISSERI Antkhappan</creator><scope>EVB</scope></search><sort><creationdate>20190605</creationdate><title>SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS</title><author>SAMALA Dzhajya Prakash ; KAMMARANO Karolin Mishel ; ROJTERSHAN Majkl Khejl ; DOLL Ronald Dzh ; PANDA Dzhagannatkh ; YAN Lipin ; BODZHEN Stefan L ; TROTTER B. Uesli ; GKHOSH Partkha ; BOLISETTI Ragkhu ; VOSS Mettyu E ; FRADERA LINAS Fransesk Ksaver ; ALTMAN Majkl D ; TOMPSON Kristofer Frensis ; MARTINES Mishel ; MASHASEK Mishell ; KRISTOFER Mettyu P ; SUN Binyuan ; SIDZUKA Manami ; TONI KURISSERI Antkhappan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2690663C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SAMALA Dzhajya Prakash</creatorcontrib><creatorcontrib>KAMMARANO Karolin Mishel</creatorcontrib><creatorcontrib>ROJTERSHAN Majkl Khejl</creatorcontrib><creatorcontrib>DOLL Ronald Dzh</creatorcontrib><creatorcontrib>PANDA Dzhagannatkh</creatorcontrib><creatorcontrib>YAN Lipin</creatorcontrib><creatorcontrib>BODZHEN Stefan L</creatorcontrib><creatorcontrib>TROTTER B. Uesli</creatorcontrib><creatorcontrib>GKHOSH Partkha</creatorcontrib><creatorcontrib>BOLISETTI Ragkhu</creatorcontrib><creatorcontrib>VOSS Mettyu E</creatorcontrib><creatorcontrib>FRADERA LINAS Fransesk Ksaver</creatorcontrib><creatorcontrib>ALTMAN Majkl D</creatorcontrib><creatorcontrib>TOMPSON Kristofer Frensis</creatorcontrib><creatorcontrib>MARTINES Mishel</creatorcontrib><creatorcontrib>MASHASEK Mishell</creatorcontrib><creatorcontrib>KRISTOFER Mettyu P</creatorcontrib><creatorcontrib>SUN Binyuan</creatorcontrib><creatorcontrib>SIDZUKA Manami</creatorcontrib><creatorcontrib>TONI KURISSERI Antkhappan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAMALA Dzhajya Prakash</au><au>KAMMARANO Karolin Mishel</au><au>ROJTERSHAN Majkl Khejl</au><au>DOLL Ronald Dzh</au><au>PANDA Dzhagannatkh</au><au>YAN Lipin</au><au>BODZHEN Stefan L</au><au>TROTTER B. Uesli</au><au>GKHOSH Partkha</au><au>BOLISETTI Ragkhu</au><au>VOSS Mettyu E</au><au>FRADERA LINAS Fransesk Ksaver</au><au>ALTMAN Majkl D</au><au>TOMPSON Kristofer Frensis</au><au>MARTINES Mishel</au><au>MASHASEK Mishell</au><au>KRISTOFER Mettyu P</au><au>SUN Binyuan</au><au>SIDZUKA Manami</au><au>TONI KURISSERI Antkhappan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS</title><date>2019-06-05</date><risdate>2019</risdate><abstract>FIELD: chemistry.SUBSTANCE: invention relates to organic chemistry and notably to specific imidazo[4,5-c]pyridine derivatives. Invention also relates to a pharmaceutical composition based on a specific imidazo[4,5-c]pyridine derivative useful in treating cancer.EFFECT: technical result is obtaining novel imidazopyridine derivatives useful as HDM2 protein inhibitors.17 cl, 1 dwg, 21 tbl, 360 ex Изобретение относится к области органической химии, а именно к конкретным производным имидазо[4,5-c]пиридина. Также изобретение относится к фармацевтической композиции на основе конкретного производного имидазо[4,5-c]пиридина, полезной для лечения рака. Технический результат: получены новые производные имидазопиридина, полезные в качестве ингибиторов HDM2 белка. 6 н. и 11 з.п. ф-лы, 1 ил., 21 табл., 360 пр.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2690663C2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A59%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAMALA%20Dzhajya%20Prakash&rft.date=2019-06-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2690663C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true